<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: BioMarin Receives Access to Priority Medicines support EMA for BMN 270 Gene Therapy in Hemophilia A	</title>
	<atom:link href="https://www.hhmglobal.com/knowledge-bank/research-insight/biomarin-receives-access-to-priority-medicines-support-ema-for-bmn-270-gene-therapy-in-hemophilia-a/feed" rel="self" type="application/rss+xml" />
	<link>https://www.hhmglobal.com/knowledge-bank/research-insight/biomarin-receives-access-to-priority-medicines-support-ema-for-bmn-270-gene-therapy-in-hemophilia-a</link>
	<description>Hospital &#38; Healthcare Management is a leading B2B Magazine &#38; an Online Platform featuring global news, views, exhibitions &#38; updates of hospital management industry.</description>
	<lastBuildDate>Thu, 06 Jul 2017 12:51:56 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
</channel>
</rss>
